Patents by Inventor Marcel Thurk

Marcel Thurk has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Peptidic thrombin inhibitors
    Patent number: 7423021
    Abstract: The invention relates to biologically active molecules, which interact with and inhibit thrombin. The invention particularly relates to molecules of general formula (I): Y1—(NH—X1—CO)—(NH—X2—C?O)—(NH—X3—C?O)—(NH—X.sup.4—C?O)—(NH—X6—C?O) (NH—X6—C?O)—Y2, wherein the compound can be used for thrombin inhibition, inhibition of fibrin formation, and/or for the inhibition of the formation of a clot. Compounds disclosed herein can also be used for treatingm, diagnosing, and prophylaxis of thrombotic disorders.
    Type: Grant
    Filed: January 15, 2004
    Date of Patent: September 9, 2008
    Assignee: NSCI Novel Science International GmbH
    Inventors: Marcel Thurk, Andreas Schwienhorst
  • Organic compounds with biological activity as thrombin inhibitors and use thereof
    Patent number: 7081447
    Abstract: The invention relates to biologically active molecules, interacting with thrombin and inhibiting the same. The invention particularly relates to molecules of general formula:Y1—(NH—X1—C?O)—(NH—X2—C?C)—(NH—X3—C?O)NH—X4—C?O)—(NH—X5—C?O)—(NH—X6—C?O)—Y2, in which Y1, Y2, and X1-6 have the meanings given in the description, N or C-terminal shortened variants of said compounds and the use thereof for the production of medicaments.
    Type: Grant
    Filed: March 10, 2004
    Date of Patent: July 25, 2006
    Assignee: Novel Science International GmbH
    Inventor: Marcel Thurk
  • Organic compounds with biological action as thrombin inhibitors and use thereof
    Publication number: 20060105959
    Abstract: The invention relates to biologically active molecules, which interact with thrombin and inhibit the same. The invention particularly relates to molecules of general fomula (I): Y1—(NH—X1—C?O)—(NH—X2—C?O)—(NH—X3—C?O)—(NH—X4—C?O)—(NH—X6—C?O) (NH—X6—C?O)—Y2, wherein Y1, Y2 and X1-6 have the meanings given in the description and N- or C-terminal abbreviated variations of said compounds and the use thereof for the production of medicaments.
    Type: Application
    Filed: January 15, 2004
    Publication date: May 18, 2006
    Applicant: CPI CREATIVE PHARMA INTERNATIONAL GMBH
    Inventors: Marcel Thurk, Andreas Schwienhorst
  • Organic compounds with biological activity as thrombin inhibitors and use thereof
    Publication number: 20050026843
    Abstract: The invention relates to biologically active molecules, interacting with thrombin and inhibiting the same. The invention particularly relates to molecules of general formula (I):Y1—(NH—X1—C=0)—(NH—X2—C?C)—(NH—X3—C=0)—NH—X4—C=0)—(NH—X5—C=0)(NH—X6—C?0)—Y2, in which Y1, Y2, and X1-6 have the meanings given in the description, N.-or C-terminal shortened variants of said compounds and the use thereof for the production of medicaments.
    Type: Application
    Filed: March 10, 2004
    Publication date: February 3, 2005
    Applicant: Novel Science International GMBH
    Inventor: Marcel Thurk